BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Diagnosis
483 results:

  • 1. braf Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms.
    Gerami P; Chen A; Sharma N; Patel P; Hagstrom M; Kancherla P; Geraminejad T; Olivares S; Biswas A; Bosenberg M; Busam KJ; de La Fouchardière A; Duncan LM; Elder DE; Ko J; Landman G; Lazar AJ; Lowe L; Massi D; Mihic-Probst D; Parker DC; Scolyer RA; Shea CR; Zembowicz A; Yun SJ; Blokx WAM; Barnhill RL
    Am J Surg Pathol; 2024 May; 48(5):538-545. PubMed ID: 38525831
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular Frontiers in Melanoma: Pathogenesis, diagnosis, and Therapeutic Advances.
    Kim HJ; Kim YH
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474231
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after braf and NRAS mutation characterisation: a single institution experience.
    Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
    Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center.
    Falcone R; Verkhovskaia S; Di Pietro FR; Poti G; Samela T; Carbone ML; Morelli MF; Zappalà AR; di Rocco ZC; Morese R; Piesco G; Marchetti P; Failla CM; De Galitiis F
    Curr Oncol; 2024 Jan; 31(1):588-597. PubMed ID: 38275835
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recent Advances in the diagnosis, Pathogenesis, and Management of Myxoinflammatory Fibroblastic Sarcoma.
    Nishio J; Nakayama S; Aoki M
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256198
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion: a case report.
    Duan R; He X; Ma X; Huang F; Hu X
    Diagn Pathol; 2024 Jan; 19(1):8. PubMed ID: 38184586
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
    Drevinskaite M; Kaceniene A; Patasius A; Stukas R; Germanavicius A; Miseikyte E; Urbonas V; Smailyte G
    Acta Psychiatr Scand; 2024 Mar; 149(3):234-243. PubMed ID: 38173088
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Metastatic Undifferentiated Melanoma Mimicking a Primary Bone Tumor: A Potential Diagnostic Pitfall.
    Wills A; Dibbern M; Frierson HF; Raghavan SS
    Am J Dermatopathol; 2024 Mar; 46(3):170-172. PubMed ID: 38170737
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
    Bafaloukos D; Kouzis P; Gouveris P; Boukovinas I; Kalbakis K; Baka S; Kyriakakis G; Moschou D; Molfeta A; Demiri S; Mavroudis D; Spanoudi F; Dimitriadis I; Gogas H
    Melanoma Res; 2024 Apr; 34(2):152-165. PubMed ID: 38092014
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Systemic therapy timing and use in patients with advanced melanoma at the end of life: A retrospective cohort study.
    van Lith PEA; Schreuder K; Jalving M; Reyners AKL; Been LB; Rácz E; Fransen HP; Louwman MWJ
    J Dermatol; 2024 Apr; 51(4):584-591. PubMed ID: 38078557
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PRAME expression in 137 primary cutaneous melanomas and comparison with 38 related metastases.
    Lo Bello G; Pini GM; Giagnacovo M; Patriarca C
    Pathol Res Pract; 2023 Nov; 251():154915. PubMed ID: 37913637
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Penile melanoma: a pathological report of two cases.
    Pósfai B; Szentkereszty M; Sánta F; Bajory Z; Simon A; Kozéki Z; Csányi I; Akgul M; Kuthi L
    Diagn Pathol; 2023 Oct; 18(1):117. PubMed ID: 37898793
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Case Report: Malignant melanoma in a patient with Crohn's disease treated with ustekinumab.
    Axiaris G; Ioannou A; Papoutsaki M; Marinos L; Liontos M; Michopoulos S; Zampeli E
    F1000Res; 2022; 11():424. PubMed ID: 37867623
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Spitz tumor with RAF1 fusion: A report of 3 cases.
    Donati M; Nosek D; Olivares S; Lemahieu J; Loontiens S; Mansour B; Gerami P; Kazakov DV
    Ann Diagn Pathol; 2023 Dec; 67():152215. PubMed ID: 37856952
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review.
    Ribeiro LM; Bomtempo FF; Rocha RB; Telles JPM; Neto EB; Figueiredo EG
    Clin Exp Metastasis; 2023 Dec; 40(6):445-463. PubMed ID: 37819546
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Primary malignant melanoma of the gall bladder masquerading as xanthogranulomatous cholecystitis.
    Kumar K; Zaidi A; Husain N; Chandra A
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37734863
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mosaic braf Fusions Are a Recurrent Cause of Congenital Melanocytic Nevi Targetable by MAPK Pathway Inhibition.
    Martin SB; Polubothu S; Bruzos AL; Kelly G; Horswell S; Sauvadet A; Bryant D; Zecchin D; Riachi M; Michailidis F; Sadri A; Muwanga-Nanyonjo N; Lopez-Balboa P; Knöpfel N; Bulstrode N; Pittman A; Yeh I; Kinsler VA
    J Invest Dermatol; 2024 Mar; 144(3):593-600.e7. PubMed ID: 37716647
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical practice consensus for the diagnosis and management of melanoma in Taiwan.
    Wu CE; Liao YH; Wu CL; Yen RF; Lin CC; Yang MH; Yen CC; Su WC; Yen CJ; Chang YF; Wu MF; Yang Y; Lin CY; Yang WC; Wang HC; Li CY; Ho YY; Chang YY; Wu CS; Hsu HC; Chen KH; Huang Y; Chen CJ; Chuang PJ; Lai YC; Huang YY; Tseng NC; Huang YT; Chu CY; Wen-Cheng Chang J
    J Formos Med Assoc; 2024 Jan; 123(1):7-15. PubMed ID: 37690868
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC braf V600-mutated melanoma.
    van Akkooi AC; Hauschild A; Long GV; Mandala M; Kicinski M; Govaerts AS; Klauck I; Ouali M; Lorigan PC; Eggermont AM
    Future Oncol; 2023 Sep; 19(30):2017-2027. PubMed ID: 37665297
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
    Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
    Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 25.